...
prtc-img

PureTech Health PLC, Common Stock

PRTC

NMQ

$21.2

-$0.6

(-2.75%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$521.94M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.05K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.99
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$19.02 L
$34 H
$21.2

About PureTech Health PLC, Common Stock

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. It also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; SPT-320, a novel prodrug of agomelatine for the treatment of generalized anxiety disorder; and SPT-348, a prodrug of a non-hallucinogenic neuroplastogen for the treatment of mood and other neuropsychiatric disorders. In addition, the company is developing hydrogels to enable the oral administration of peptide therapeutics in preclinical development. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FramePRTCSectorS&P500
1-Week Return-3.35%-3.39%0.2%
1-Month Return1.16%-1.92%2.72%
3-Month Return11.26%-10.54%7.31%
6-Month Return-24.28%-4.47%10.44%
1-Year Return15.4%4.06%27.53%
3-Year Return-47.04%0.94%30.88%
5-Year Return-43.38%36.67%89.21%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue8.69M8.34M9.98M2.09M3.33M[{"date":"2019-12-31","value":87.06,"profit":true},{"date":"2020-12-31","value":83.59,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":20.94,"profit":true},{"date":"2023-12-31","value":33.37,"profit":true}]
Cost of Revenue--110.47M152.43M4.93M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":72.47,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":3.24,"profit":true}]
Gross Profit8.69M8.34M(100.49M)(150.34M)(1.60M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":96.01,"profit":true},{"date":"2021-12-31","value":-1156.68,"profit":false},{"date":"2022-12-31","value":-1730.47,"profit":false},{"date":"2023-12-31","value":-18.45,"profit":false}]
Gross Margin100.00%100.00%(1007.03%)(7193.44%)(48.14%)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-1007.03,"profit":false},{"date":"2022-12-31","value":-7193.44,"profit":false},{"date":"2023-12-31","value":-48.14,"profit":false}]
Operating Expenses144.09M127.87M160.26M199.90M146.95M[{"date":"2019-12-31","value":72.08,"profit":true},{"date":"2020-12-31","value":63.97,"profit":true},{"date":"2021-12-31","value":80.17,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":73.51,"profit":true}]
Operating Income(135.40M)(119.53M)(150.28M)(197.81M)(146.20M)[{"date":"2019-12-31","value":-13539900000,"profit":false},{"date":"2020-12-31","value":-11953100000,"profit":false},{"date":"2021-12-31","value":-15028200000,"profit":false},{"date":"2022-12-31","value":-19780700000,"profit":false},{"date":"2023-12-31","value":-14619900000,"profit":false}]
Total Non-Operating Income/Expense579.55M136.74M86.83M106.87M112.62M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":23.59,"profit":true},{"date":"2021-12-31","value":14.98,"profit":true},{"date":"2022-12-31","value":18.44,"profit":true},{"date":"2023-12-31","value":19.43,"profit":true}]
Pre-Tax Income478.47M18.97M(58.95M)(92.78M)(36.10M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":3.96,"profit":true},{"date":"2021-12-31","value":-12.32,"profit":false},{"date":"2022-12-31","value":-19.39,"profit":false},{"date":"2023-12-31","value":-7.55,"profit":false}]
Income Taxes112.41M14.40M3.76M(55.72M)30.52M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":12.81,"profit":true},{"date":"2021-12-31","value":3.34,"profit":true},{"date":"2022-12-31","value":-49.57,"profit":false},{"date":"2023-12-31","value":27.16,"profit":true}]
Income After Taxes366.06M4.57M(62.71M)(37.06M)(66.63M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":1.25,"profit":true},{"date":"2021-12-31","value":-17.13,"profit":false},{"date":"2022-12-31","value":-10.12,"profit":false},{"date":"2023-12-31","value":-18.2,"profit":false}]
Income From Continuous Operations366.06M4.57M(62.71M)(37.06M)(66.63M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":1.25,"profit":true},{"date":"2021-12-31","value":-17.13,"profit":false},{"date":"2022-12-31","value":-10.13,"profit":false},{"date":"2023-12-31","value":-18.2,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income421.14M4.57M(62.71M)(37.06M)(65.70M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":1.08,"profit":true},{"date":"2021-12-31","value":-14.89,"profit":false},{"date":"2022-12-31","value":-8.8,"profit":false},{"date":"2023-12-31","value":-15.6,"profit":false}]
EPS (Diluted)1.501.47---[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":98.05,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

PRTC
Cash Ratio 3.62
Current Ratio 3.68
Quick Ratio 2.30

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PRTC
ROA (LTM) -13.39%
ROE (LTM) -22.07%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PRTC
Debt Ratio Lower is generally better. Negative is bad. 0.47
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.54

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PRTC
Trailing PE NM
Forward PE NM
P/S (TTM) 1115.25
P/B 1.65
Price/FCF NM
EV/R 348.82
EV/Ebitda NM

FAQs

What is PureTech Health PLC share price today?

PureTech Health PLC (PRTC) share price today is $21.2

Can Indians buy PureTech Health PLC shares?

Yes, Indians can buy shares of PureTech Health PLC (PRTC) on Vested. To buy PureTech Health PLC from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PRTC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of PureTech Health PLC be purchased?

Yes, you can purchase fractional shares of PureTech Health PLC (PRTC) via the Vested app. You can start investing in PureTech Health PLC (PRTC) with a minimum investment of $1.

How to invest in PureTech Health PLC shares from India?

You can invest in shares of PureTech Health PLC (PRTC) via Vested in three simple steps:

  • Click on Sign Up or Invest in PRTC stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in PureTech Health PLC shares
What is PureTech Health PLC 52-week high and low stock price?

The 52-week high price of PureTech Health PLC (PRTC) is $34. The 52-week low price of PureTech Health PLC (PRTC) is $19.02.

What is PureTech Health PLC price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of PureTech Health PLC (PRTC) is

What is PureTech Health PLC price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of PureTech Health PLC (PRTC) is 1.65

What is PureTech Health PLC dividend yield?

The dividend yield of PureTech Health PLC (PRTC) is 0.00%

What is the Market Cap of PureTech Health PLC?

The market capitalization of PureTech Health PLC (PRTC) is $521.94M

What is PureTech Health PLC’s stock symbol?

The stock symbol (or ticker) of PureTech Health PLC is PRTC

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top